# Tennessee Reproductive Medicine – FDA Inspection, Aug 4, 2022

Source: https://www.keypedia.com/records/fda_inspections/tennessee-reproductive-medicine/ebead5de-0097-434c-9354-2eb7f9383c35
Source feed: FDA_Inspections

> FDA inspection 1176463 of Tennessee Reproductive Medicine, August 04, 2022. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176463
- Company Name: Tennessee Reproductive Medicine
- Inspection Date: 2022-08-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1224648 - 2023-12-05](https://www.keypedia.com/records/fda_inspections/tennessee-reproductive-medicine/681f13c1-006b-493d-a9d4-b3f2c4bfc027)
- [FDA Inspection 1065574 - 2018-09-11](https://www.keypedia.com/records/fda_inspections/tennessee-reproductive-medicine/b92095a1-f411-41f9-85d2-6433ebf81663)
- FDA Inspection 960961 - 2016-02-10
- FDA Inspection 880769 - 2014-05-28
- FDA Inspection 805705 - 2012-10-31

Company: https://www.keypedia.com/companies/tennessee-reproductive-medicine/27ca45aa-cb16-495d-ab07-c1464d6e5292

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
